NO | ଉତ୍ପାଦଗୁଡିକ | କାସ ନା | ମୁଖ୍ୟ ଗୁଣବତ୍ତା ସୂଚକ | | |||
ଶୁଦ୍ଧତା | ସର୍ବାଧିକ ଅପରିଷ୍କାରତା | ସମୁଦାୟ ଦ୍ରବଣୀୟ ଅବଶିଷ୍ଟ | | ଆର୍ଦ୍ରତା | |||
1 | FMOC-β-ALA-ALA-ALA-OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
2 | FMOC-D-ALA-D-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
3 | FMOC-β-ALA-D-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
4 | FMOC-ARG (PBF) -AG (PBF) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
5 | FMOC-β-ALA-ALA-ALA-ALA- | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
6 | FMOC-D- ଯୁଗ (pbf) -d-neg (pbf) -oh | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
7 | FMOC-β-ALA-D-D-D-AGH (PBF) -ୋଜ୍ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
8 | FMOC-HOGARG (PBF) -ହୋମାର୍ଗ୍ (PBF) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
9 | FMOC-β-ALA-ALA-HOMARG (PBF) -H | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
10 | FMOC-ASN (TRT) -ASN (TRT) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
11 | FMOC-β-ALA-ALN (TRT) -H | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
12 | FMOC-ASP (Otbu) -asp (ଓଟବୁ) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
13 | FMOC-β-ALA-ASP (Otbu) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
14 | FMOC-CYS (TRT) -CYS (TRT) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
15 | FMOC-β-ALA-SYS (TRT) -H | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
16 | FMOC-CYS (ACM) -CYS (ACM) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
17 | FMOC-β-ALA-CYS (ACM) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
18 | FMOC-GLN (TRT) -GLN (TRT) -H | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
19 | FMOC-β-ALA-GLN (TRT) -H | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
20 | FMOC-GLU (OTBU) -glu (OTBU) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
21 | FMOC-β-ALA-GLU (OTBU) -OH.H2O | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
22 | FMOC-β-ALA-GLY-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
23 | FMOC-HE (TRT) -HIS (TRT) -ହୋ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
24 | FMOC-β-ALA-ALA-HE (TRT) -H | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
25 | FMOC-Ile-Ile-Oh | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
26 | FMOC-β-ALA-Ile-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
27 | FMOC-LEU-LEU-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
28 | FMOC-β-ALA-LEU-O OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
29 | FMOC-D-LEU-D-LEU-OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
30 | FMOC-β-ALA-D-LEU-O OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
31 | FMOC-LYS (BOC) - (BOC) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
32 | FMOC-β-ALAY (BOC) -H | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
33 | FMOC-LYS (ALLOC) - ଆଚ୍ଛା (ALLC) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
34 | FMOC-β-ALAY (ALLOG) -H | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
35 | FMOC-MEN- TEL- OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
36 | FMOC-β-ALA-TEL- OH OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
37 | FMOC-ORN (BOC)-ERON (BOC) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
38 | FMOC-β-ALA-ALA-ORN (BOC) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
39 | FMOC-PHE-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
40 | FMOC-β-ALA-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
41 | FMOC-D-PHE-D-PHE-OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
42 | FMOC-β-ALA-D-PHE-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
43 | FMOC-Pro-Pro-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
44 | FMOC-β-ALA-PRO-OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
45 | FMOC-ser (tbu) -ser (Tbu) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
46 | FMOC-β-Ala-ser (Tbu) -h | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
47 | FMOC-ser (trt) -ser (trt) -oh | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
48 | FMOC-β-Ala-ser (trt) -hol | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
49 | FMOC-THR (Tbu) -thr (tbu) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
50 | FMOC-β-ALA-THR (TBU) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
51 | FMOC-TRP (BOC) --rp (BOC) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
52 | FMOC-β-ALA-TRP (BOC) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
53 | FMOC-D-TRP (BOC) -d-trp (Boc) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
54 | Fmoc-β-Ala-d-trp (boc) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
55 | FMOC-Tyr (Tbu) -tyr (tbu) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
56 | FMOC-β-Ala-tyr (tbu) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
57 | FMOC-D-TYR (ET) -D-TYR (ET) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
58 | FMOC-β-ALA-D-D-TYR (ET) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
59 | FMOC-Tyr (me) -tyr (me) -oh | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
60 | FMOC-β-ALA-Ty-Tyr (me) -oh | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
61 | FMOC-VAL-VAL-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
62 | FMOC-β-ALA-VAL-AHT | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
63 | FMOC-D-KIT-DI CIT-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
64 | FMOC-β-ALA-D-CIT-OH OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
65 | FMOC-β-ALA-DAB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
66 | FMOC- (୨-NAAPHTHIL) -d-ALA) 2-ଓ oh | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
67 | FMOC-β-ALA-ALA-3- (2-NAAPHTHIL) -D-ALA-OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
68 | FMOC- (3- ୨-ପିଆଡିନିଲ୍) -d-ALA) 2-ଓ oh | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
69 | FMOC-β-ALA-ALA-3- (3-ପିଆଡରିଲ୍) -d-ALA-OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
70 | FMOC- (4-କ୍ଲୋରୋ-ଡି-ପେ) 2-ଓ oh | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
71 | FMOC-β-ALOO- CLLORO-D-PHE-OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
72 | FMOC- (D-4AH (TBUCBM)) 2-OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
73 | FMOC-β-ALA-D-D-C -AH (TBUCBM) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
74 | FMOC-APH (L-HOR) -AHH (L-HOR) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
75 | FMOC-β-ALA-APH (L-HOR) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
76 | FMOC-LYS (IPR, BOC) - IPR, BOC) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
77 | FMOC-β-ALA-ALS (IPR, BOC) -ୋଜ୍ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
78 | FMOC-β-ALA-AEAA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
79 | FMOC-AIB-AIB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
80 | FMOC-β-ALA-AIB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
81 | FMOC-ARG-OH | 91000-69-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
82 | H- ଯୁଗ (pbf) -ହ | | 200115-2-2-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
83 | FMOC-D-ARG-OH | 130752-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
84 | HD-ARG (PBF) -OH | 200116-81-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
85 | FMOC-EMORG-OH.HCL | | 208174-14-5- | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
86 | H- ହୋମରଗ୍ (PBF) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
87 | FMOC-D-WOMARG-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
88 | HD-EMORG (PBF) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
89 | FMOC-ASN-OH | 71989-16-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
90 | H-Asn (trt) -oh | 132388-58-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
91 | FMOC-ASP-OH | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
92 | H-Asp (Otbu) -ହ | | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
93 | FMOC-CYS-OH | 135248-89-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
94 | H-CYS (TRT) -OH | 2799/7/7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
95 | H-CYS (ACM) -OH.HCCL | | 28798-28-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
96 | FMOC-GLN-OH | 71989-20-3-3-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
97 | H-GlN (TRT) -OH | 102747-84-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
98 | FMOC-GLU-OH | 121343-82-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
99 | H- ଗ୍ଲୁ (ଓଥୁ) -oh.h2o | 2419-56-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
100 | FMOC-ତାଙ୍କର-ଓହ | | 116611-4-4-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
101 | H-ତାଙ୍କର (TRT) -OH | 35146-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
102 | Boc-ho | 17791-52-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
103 | FMOC-LYS-OH | 105047-4-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
104 | H-LYS (BOC) -ହ | | 2418-95-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
105 | H-lys (ALLL) -OH | | 6298/3/9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
106 | FMOC-OHN-OH.HCL | | 201046-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
107 | H-orn (boc) -ହ | | 13650-49-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
108 | FMOC-Sew-OH | 73724-4-4-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
109 | H-ser (tbu) -ହ | | 188222-58-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
110 | H-ser (trt) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
111 | FMOC-THR-OH.H2O | | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
112 | H-thr (tbu) -oh | 4378-13-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
113 | FMOC-TRP-OH | 35737-15-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
114 | H- TRP (BOC) -OH | | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
115 | FMOC-D-TRP-OH | 86123-1-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
116 | HD-TRP (BOC) -ହ | | 201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
117 | FMOC-Tyr-Oh | 92954-90-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
118 | H-Tyr (Tbu) -ହ | | 18822-59-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
119 | FMOC-D-Tyr-Oh | 112883-29-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
120 | HD-Tyr (et) -oh | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
121 | H-Tyr (me) -oh.lcl | | 67423-44-3-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
122 | FMOC-D-4AH (CBM) -ହ | | 324017-22-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
123 | HD-4AH (TBUCBM) -OH | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
124 | FMOC-LYS (IPR) -ହ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
125 | H-LYS (IPR, BOC) -ୋଜ୍ | | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
କ୍ଷତିପୂରଣ
ଜେନୋଲିକ୍ସ ବହୁତ ଭଲ ଗୁଣବତ୍ତା ଉତ୍ପାଦ ପ୍ରଦାନ କରିଥାଏ, ଯଦି ପର୍ଯ୍ୟାପ୍ତ ପରିମାଣର ପ୍ରମାଣ ସହିତ ଆବଶ୍ୟକ ସମୟ ସୀମା ମଧ୍ୟରେ ଯେକ Any ଣସି ଉତ୍ପାଦ ଗୁଣକୁ କ୍ଲାଏଣ୍ଟ ଦ୍ୱାରା ବିମୁଖାଯାଉଛି, ତେବେ ଫେରସ୍ତ
ଉତ୍ପାଦନ
ଫାର୍ମାସ୍ୟୁଟିକାଲ୍ ଉତ୍ପାଦଗୁଡିକର କ୍ଷମତା ଟନ୍ ଗ୍ରେଡ୍ ରେ ପହଞ୍ଚିଛି, ରାସାୟନିକ ଉତ୍ପାଦଗୁଡିକର ସାମଗ୍ରୀର 100tons + ଗ୍ରେଡ୍ ରେ ପହଞ୍ଚିଛି, ସାମର୍ଥ୍ୟଗୁଡିକ ବିଶ୍ worldwide ବ୍ୟାପୀ ଗ୍ରାହକମାନଙ୍କୁ ସେବା କରିବା ପାଇଁ ସଜ୍ଜିତ |
ଅନୁସନ୍ଧାନ ଏବଂ ବିକାଶ
ପ୍ରତିବର୍ଷ, ଟାର୍ଗେଟ୍ ସେଟ୍ ସେଟ୍ ହୋଇଥିବାବେଳେ, ଟାର୍ଗେଟ୍ ସେଟ୍ ହୁଏ, ଯେତେବେଳେ ଟାର୍ଗେଟ୍ ସେଟ୍ ହୁଏ, ସେତେବେଳେ ବିଭିନ୍ନ ନୂତନ ଉତ୍ପାଦଗୁଡ଼ିକର ବିକାଶ କରିବାକୁ ଯୋଜନା ପାଖରେ R & d ଦଳ ଦ୍ୱାରା ଯୋଜନା ଅଛି, ଯେତେବେଳେ ଟାର୍ଗେଟ୍ ସେଟ୍ ହୁଏ, ଦଳରେ କେପି ଦାୟିତ୍ and ଏବଂ ପ୍ରୋତ୍ସାହନ ନୀତି ସହିତ ଚାଲିବାକୁ ପଡିବ |